Manifold MarketsKYC yokDoğrulanmış sonuçlanma verisiOrta düzey kalibreGüncel topluluk tahminiHayır 85.7%
Tahminciler
18
Soru türü
binary
Yöntem
Play-money forecasting platform
Kaynak türü
Tahmin
Piyasa verileri
5 saat önce güncellendi
Guncelligini yitirmis3 Ağu 23 18:56 UTC2 Oca 28 07:59 UTC
Trendler
Kurallar
Recently the small molecule drug AOH1996 has recieved some attention on social media for its potential to treat a variety of cancers with basically no side effects in animal models.
- Here is a good overview: https://www.science.org/content/blog-post/new-mode-cancer-treatment
- The question here is whether this drug will succeed in Phase II trials.
- Unlike the ongoing Phase I trials, which are designed to show safety, Phase II trails must show efficacy.
- Success can unambiguously be defined as either FDA approval (under an accelerated approval process, which this drug may get) or advancing to Phase III trails.
- (Note that in Phase III trials a drug is evaluated for comparative efficacy against other treatment options).
